Pfizer expects to produce at least 3 billion COVID-19 vaccine doses next year

Pfizer CEO Albert Bourla says the company expects to produce at least 3 billion doses of the vaccine in 2022.

5/4/2021 6:46:00 PM

Pfizer CEO Albert Bourla says the company expects to produce at least 3 billion doses of the vaccine in 2022.

Pfizer CEO Albert Bourla says the company expects to produce at least 3 billion doses of the vaccine in 2022.

(CNN) - Pfizer CEO Albert Bourla said Tuesday the company has been contracted to deliver 1.6 billion doses of its COVID-19 vaccine globally this year, and the company expects to produce at least 3 billion doses of the vaccine in 2022. The company is in discussions with countries for multi-year contracts of potential supply.

Prosecutor Bensouda: Duterte policy enabled killings and cover-up Expert: Face shields extra barrier vs Delta variant What Rizal taught us about the pitfalls of spreading and reading fake news

Bourla said the company is expecting approximately $26 billion in revenue from its COVID-19 vaccine in 2021.Pfizer says it’s not yet clear how long the vaccine will protect against COVID-19, but Bourla said demand for the vaccine is expected to remain high. “Based on what we’ve seen, we believe that a durable demand for our COVID-19 vaccine – similar to that of the flu vaccines – is a likely outcome,” Bourla said.

In addition to testing a third dose as a booster against variants, Bourla said, Pfizer is also working on a version of the vaccine that specifically targets the B.1351 variant, which was first identified in South Africa. According to Bourla, efficacy data for both the booster and the B.1351 specific vaccine would be available in early July. He noted that the study design of the B.1351 variant vaccine would potentially be a prototype so that Pfizer could update it to target new variants of concern in approximately 100 days.

Bourla also said the company was working on trialing two antiviral treatments to treat COVID-19, one administered as a shot and the other orally. The company expects to begin phase 2/3 trials of these treatments this summer and anticipates applying for approvals by the end of the year. The treatments will be tested for their efficacy in treating COVID-19 and will be evaluated against the current monoclonal antibody treatment for COVID-19. They will also be tested as a potential prophylaxis, testing in unvaccinated households that have a COVID-19 infection to see if it prevents additional infections.

Read more: CNN Philippines »

Facebook starts labeling state-controlled media in PH

A measure that first rolled out in the US in June 2020 now applies to Philippine pages

This video shows you my experience on getting the Covid vaccine and how it is starting to change my life for the good (open up the world again)! Check it out! Enjoy! VaccinesWork healthyliving youtube antiaging yolo COVID19 vaccinated WE WILL WAIT FOR THE WESTERN-MADE VACCINES UNTIL HELL FREEZES OVER. SINOVAC/SINOPHARM VACCINES ARE CUSTOM MADE FOR THE COWARDS.

Pfizer to seek authorization for COVID-19 vaccine for children ages 2 to 11 in SeptemberThe company's vaccine safety and efficacy study in children age 6 months to 11 years old is still going. *Search for the Channel'LADSBROKE'on TELEGRAM.betting superstar with punting odds.*

Makati begins use of Pfizer COVID-19 jabsThe initial inoculation of the awaited vaccine brand to an expected 300 to 500 people the first day went smoothly, said the hospital's medical director Dr. Saturnino Javier. sana all PFIZER. How we wish FRONTLINERS USED those Pfizers... Bakit inuna yan hindi ung mageexpire na na astra? 🧐

South Korea says AstraZeneca, Pfizer COVID-19 vaccines 87% effective after first shotThe analysis is based on more than 3.5 million people in South Korea aged 60 and older for two months from Feb. 26 and included 521,133 people who received a first dose of either Pfizer or AstraZeneca shot. Meanwhile the DDS choice Sinovac is 50% effective. Taking it is like playing 'sa pula sa puti'. How about yung China Farm 👟🧫🧪🌡️🧬💉💊 AstraZeneca pfizer WHO

Pfizer COVID-19 vaccines may arrive in Philippines in MaySome 193,000 doses of the Pfizer-BioNTech vaccine may reach the country on May 11.

Canada authorizes Pfizer COVID-19 vaccine for children aged 12 to 15Canada is authorizing the use of Pfizer Inc’s COVID-19 vaccine for use in children from 12 to 15, the first dose to be allowed for people that young, the federal health ministry said on Wednesday. | reuters